Uso de cloramina-T e de dois corantes na determinação sensível de estavudina em medicamentos by Basavaiah, Kanakapura et al.
Revista Brasileira de Ciências Farmacêuticas
Brazilian Journal of Pharmaceutical Sciences
vol. 43, n. 3, jul./set., 2007
Use of chloramine-T and two dyes in the sensitive determination of
stavudine in pharmaceuticals
Kanakapura Basavaiah1*, Veeraiah Ramakrishna2, Urdigere Rangachar Anilkumar1
1Department of Chemistry, University of Mysore, India, 2Department of Drugs Control,
Govt. College of Pharmacy, India
Three new methods are described for the assay of stavudine (STV)
in bulk drug and in dosage forms using chloramine-T (CAT) and
two dyes, methyl orange and indigocarmine, as reagents. Titrimetry
involves treating STV with a measured excess of CAT in
hydrochloric acid medium, and after the oxidation of STV is judged
to be complete, the unreacted oxidant is determined iodometrically.
Spectrophotometric methods entail the addition of a known excess
of CAT to STV in hydrochloric acid medium followed by
determination of residual oxidant by reacting with a fixed amount
of either methyl orange and measuring the absorbance at 520 nm
(Method A) or indigo carmine and measuring the absorbance at
610 nm (Method B). In all the methods, the amount of CAT reacted
corresponds to the amount of STV. In titrimetric method, the
reaction follows 1:1 stoichiometry (STV: CAT), and is applicable
over the range 1.5-10 mg of STV. In spectrophotometric methods,
the absorbance is found to increase linearly with concentration of
STV. The systems obey Beer’s law for 0.2-2.0 and 1.0-10.0 μg/mL
for method A and method B, respectively. The apparent molar
absorptivities are calculated to be 5.7x104 and 1.5x104 L/mol/cm
for method A and method B, respectively, and the corresponding
Sandell sensitivity values are 0.004 and 0.015 µg/cm2. The limits
of detection and quantification are reported for both methods.
Intra-day and inter-day precision and accuracy of the developed
methods were evaluated as per the current ICH guidelines. The
methods were successfully applied to the assay of STV in tablet
and capsule formulations and the results were compared with those
of a reference method by applying Student’s t-test and F-test. No
interference was observed from common tablet adjuvants. The
accuracy and reliability of the methods were further ascertained
by performing recovery experiments via standard-addition method.
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INTRODUCTION
Stavudine (STV), chemically known as 21-31-
didehydro -21-31- dideoxythymidine (Figure 1), is a
nucleoside analog reverse transcriptase inhibitor (NARTI)
active against HIV (Merck Index, 1996). STV is converted
intracellularly to triphosphate which stops the DNA
synthesis of retroviruses through competitive inhibition of
reverse transcriptase and incorporation into viral DNA. It
is the fourth antiretroviral drug in the market and is used in
the treatment of HIV infection. The drug is official in
United States Pharmacopeia (USP, 2006). which describes
high performance liquid chromatographic procedures for
bulk drug and tablets.
A number of methods based on high performance
liquid chromatography (Bezy et al. 2005; Verweij-van
Wissen et al. 2005; Contreras et al. 2004), liquid
chromatography-tandem mass spectrometry (Compain et
al., 2005; Huang et al., 2004; Raices et al., 2003, Fan et
al., 2002; Weisner et al., 2002), micellar electrokinetic
chromatography (Fan and Stewart. 2002) and electro-
phoresis (Pereira et al ., 2005) are known for the
quantitative determination of STV in biological matrices
such as blood plasma, blood serum and human cells.
Several chromatographic techniques including HPLC
(Dunge et al., 2005; Djurdjevic et al., 2004; Zhang et al.,
2003; Sablon et al., 2004; Pai and Desai. 2003; Rezk et al.,
2003), HPTLC (Wankhede et al., 2005; Kaul et al., 2005)
and LC-MS (Volosov et al., 2002), have been used for the
determination of STV in pharmaceuticals. The drug has
also been assayed by mass spectrometry (Soldin, 2004) and
UV-spectrophotometry (Sankar et al., 2002).
Despite its long history and established versatility, no
titrimetric method has yet been reported for the deter-
mination of STV in pharmaceuticals. Visible spectro-
photometry, because of its simplicity, speed, sensitivity,
reasonable accuracy and precision, and cost-effectiveness,
continues to be the preferred technique in laboratories of
developing and underdeveloped nations, which can illafford
expensive chromatographic and related techniques. Three
procedures (Sarma et al., 2002) have been reported for the
assay of STV in pharmaceuticals using Potassium
permanganate-Fast Green FCF, permanganate/periodate-
3-methylbenzothiazolinone hydrazone (MBTH) and
iron(III)chloride-ferricyanide as reagents. The same
authors (Sarma et al., 2002) have used three more reagents,
N-bromosuccinimide (NBS)-celestine blue, cobalt
thiocyante and ammonium molybdate for the spectro-
photometric determination of STV. A method based on
oxidative-coupling reaction (Sankar et al., 2002) involving
the use of iron (III)-MBTH is also found in the literature.
But, these methods suffer from one or the other
FIGURE 1 - Tentative reaction scheme.
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disadvantage like poor sensitivity, heating or extraction step
and/or use of expensive chemical/organic solvent.
In this communication, we report one titrimetric and
two spectrophotometric methods for the determination of
STV in bulk drug and in pharmaceutical formulations. The
methods are based on the oxidation of STV by CAT
followed by estimation of unreacted oxidant by iodometric
back titration (titrimetry) or reacting with a fixed amount
of dye (spectrophotometry). The methods were applied to
the determination of STV in different proprietary drugs and
were found to yield satisfactory results.
EXPERIMENTAL
Apparatus
A Systronics model 106 digital spectrophotometer
with 1-cm matched quartz cells was used for all absorbance
measurements.
Reagents and materials
All chemicals used were of analytical reagent grade
and distilled water was used to prepare all solutions.
Chloramine-T solution (0.01M) was prepared by
dissolving about 2.8 g of the chemical (Qualigens Fine
Chem., Glaxo India Ltd., Mumbai) in water and diluting to
1 litre, and used in titrimetry after standardization ( Berka
et al., 1965). For spectrophotometric investigation, the
above solution was diluted appropriately with water to get
50.0 and 225.0 µg/mL concentrations for method A and
method B, respectively. To prepare 50.0 µg/mL methyl
orange for method A, first, a 500.0 µg/mL dye solution was
prepared by dissolving 59.0 mg of dye (s.d. Fine Chem
Ltd., Mumbai, assay 85%) in water and diluting to 100 mL
in a calibrated flask, and filtered using glass wool. This was
diluted ten-fold with water to get the required
concentration. For method B, first, a 1000.0 µg/mL indigo
carmine solution was prepared by dissolving 112.0 mg of
dye (s.d.Fine-Chem Ltd., Mumbai, 90% assay) in water
and diluting to 100 mL, and filterd. This was appropriately
diluted with water to get 200.0 µg/mL. Hydrochloric acid
(5.0, 2.0 or 1.0 M) was prepared by diluting concentrated
acid (s.d. Fine-Chem Ltd., Mumbai, Sp gr 1.18)
appropriately with water. Sodium thiosulphate solution
(0.02 M) was prepared by dissolving about 5.0 g of the
TABLE I - Comparison of performance characteristics of proposed methods with the existing spectrophotometric methods
Sl Reagent* λmax, nm Linear range, ∈, Remarks Ref.
No. μg/ mL L/mol/cm
1 a) NBS-celestine 540 0.7-6.0 1.6×104 NBS requires daily Sarma et
     blue standardisation al. 2002
b) Cobalt thiocyante 610 1.5-15.0 7.7×103 Involves extraction step
with organic solvent,
less sensitive
c) Ammonium 700 11.0-150.0 1.0×103 Requires heating;
    molybdate least sensitive.
2 Iron (III)-MBTH Longer contact time, Sankar et
expensive chemical al. 2002
3 a) KMnO4-Fast 640 1.0-8.0 1.28×10
4 Less sensitive Sharma et
     green FCF al. 2002
b) KMnO4/NaIO4- 620 0.6-6.0 2.02×104 Longer contact time,
     MBTH expensive chemical
c) Iron (III)- 740 9.0-75.0 1.24×103 Less sensitive
    ferricyanide
4 a) CAT- 520 0.2-2.0 5.7×104 Highly sensitive,wide Present
     methylorange linear dyanamic ranges, methods
b) CAT- 610 0.5-10 1.5×104 no heating/extraction,
     indigocarmine shorter reaction time
inexpensive chemicals
* MBTH. 3-methylbenzothiazolinone hydrazone; NBS. N-bromosuccinimide.
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chemical (SISCO Chem, Industries, Mumbai) in 1 litre of
water and standardized with pure potassium dichromate
iodometrically (Bassett et al., 1978). Aqueous solutions of
potassium iodide (10%) and starch indicator (1%) were
prepared in the usual way. Pharmaceutical grade STV,
certified to be 99.8% pure, was received from Cipla India
Ltd, Mumbai, India, as gift and was used as received. A 1.0
mg/mL solution of STV was prepared by dissolving
accurately weighed 250.0 mg of pure drug in water and
diluting to 250 mL with water in a calibrated flask and used
for assay by titrimetry. This stock solution (1000.0 µg/mL)
was diluted with water to get working concentrations of 5.0
and 20.0 μg/mL STV for method A and method B,
respectively.
Methods
Titrimetry
A 10.0 mL aliquot of pure drug solution equivalent to
1.5-10.0 mg of STV was measured accurately and
transferred into a 100 mL titration flask. Five mL 1 M
hydrochloric acid followed by 10 mL of 0.01 M CAT
solution were added and kept aside for 10 min with
occasional swirling. Then, 5 mL of 10% potassium iodide
solution were added to the flask and the liberated iodine was
titrated with 0.02 M sodium thiosulphate to a starch end
point. A blank titration was run under same conditions. The
amount of the drug present in the measured aliquot was
calculated from the volume of CAT that has reacted with
the drug.
Spectrophotometric method using methyl orange
(Method A)
Aliquots of pure STV solution (0.4 to 4.0 mL;
5.0 µg/mL) were transferred into a series of 10 mL
calibrated flasks and the total volume was adjusted to 4.0
mL with water. To each flask were added 1 mL of 5 M
hydrochloric acid followed by 1 mL of CAT solution
(50.0 µg/mL). The content was mixed well and the flasks
were set aside for 10 min with occasional shaking. Finally,
1 mL of 50.0 µg/mL methyl orange solution was added to
each flask, diluted to the mark with water and the
absorbance of solution was measured at 520 nm against
reagent blank after 10 min.
Spectrophotometry with indigo carmine (Method B)
Varying aliquots (0.5-5.0 mL) of standard 20.0 µg/mL
STV solution were measured accurately and delivered into
a series of 10 mL calibrated flasks and the total volume was
brought to 5.0 mL with water. To each flask were added
2 mL each of 2 M hydrochloric acid and 200.0 µg/mL
chloramine-T solutions successively; the flasks were let
stand for 10 min with occasional shaking. Then, 1 mL of
200.0 µg/mL indigo carmine solution was added to each
flask, the volume was adjusted to the mark with water and
mixed well. The absorbance of each solution was measured
at 610 nm against a reagent blank after 10 min.
In either spectrophotometric method, the
concentration of the unknown was read from the calibration
graph or computed from the regression equation derived
from the Beer’s law data.
Assay procedure for formulations
An amount of finely ground tablet/capsule powder
equivalent to 100.0 mg of STV was accurately weighed into
a 100 mL calibrated flask, 60 mL of water added and
shaken for 20 min. Then, the volume was made up to the
mark with water, mixed well, and filtered using a Whatman
No 42 filter paper. First 10 mL portion of the filtrate was
discarded and a suitable aliquot of the subsequent portion
(1.0 mg/mL STV) was taken for assay by titrimetric
procedures. The filtrate was diluted appropriately to get 5.0
and 20.0 µg/mL STV concentrations for analysis by
spectrophotometric method A and method B, respectively.
RESULTS AND DISCUSSIONS
The proposed methods are based on the oxidation of
STV by CAT in HCl medium and the reaction is followed
by titrimetry and spectrophotometry for quantization
purposes. In titrimetry, the unreacted CAT is determined
iodometrically, and in spectrophotometric methods, the
same is determined by reacting with a fixed amount of
either methyl orange or indigo carmine. The latter methods
make use of the bleaching action of chloramine-T on either
dye, the decolouration being caused by the oxidative
destruction of the dye.
Optimisation of experimental conditions
Titrimetry
The reaction stoichiometry was found to be 1:1(STV:
CAT) which was unaffected in the presence of 3 to 8 mL of
1M HCl in a total volume of 25 mL and hence 5 mL of 1M
HCl was chosen as the optimum volume. The oxidation
reaction was found to be complete in 10 min and contact
time upto 30 min had no effect on the stoichiometry or the
results. A 10 mL volume of 0.01M CAT solution was found
adequate for the quantitative oxidation of STV in 1.5 to
10.0 mg range. The linearity between the amount of drug
and titration end point is apparent from the calculated
correlation coefficient of –0.9964 suggesting that the
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reaction between STV and CAT proceeds stoichio-
metrically in the ratio of 1:1, in the optimum range (1.5-
10.0 mg). Based on the reaction stoichiometry, a tentative
reaction scheme shown in Figure 1 is suggested.
Spectrophotometry
In the proposed spectrophotometric methods, the
ability of CAT to effect oxidation of STV and irreversibly
destroy methyl orange or indigo carmine to colourless
products in acid medium has been used. STV when added
in increasing concentrations to a fixed concentration of
CAT, consumes the latter and there will be a concomitant
decrease in its concentration. When a fixed concentration
of either dye is added to decreasing concentrations of CAT,
a concomitant increase in the concentration of dye results
and a proportional increase in the absorbance at the
respective λmax is observed with increasing concentration of
STV.
Preliminary experiments were performed to fix the
upper limits of the dyes that could be determined
spectrophotometrically, and these were found to be 5.0 and
20.0 µg/mL for methyl orange and indigo carmine,
respectively. A CAT concentration of 5.0 µg/mL was found
to irreversibly destroy the red colour of 5.0 µg/mL methyl
orange whereas 20.0 µg/mL CAT was required to bleach
the blue colour due to 22.5 µg/mL indigo carmine. Hence,
different amounts of STV were reacted with 1 mL of
50.0 µg/mL CAT in method A and 1mL of 225.0 µg/mL
CAT in method B followed by determination of the residual
oxidant as described under the respective procedures.
For both oxidation of STV and bleaching of dye by
CAT, hydrochloric acid medium was found to be ideal. One
mL of 5 M hydrochloric acid for method A and 2 mL of 2 M
HCl for method B, in a total volume of ~4-5 mL were
adequate for the oxidation step which was complete in
10 min in both methods and the same quantity of acid was
employed for the estimation of the dye. Contact time of
10 min is not critical and any delay upto 30 min had no
effect on the absorbance. The absorbance of either dye
colour was stable for several hours in the presence of
reaction product.
Analytical data
A linear correlation was found between absorbance
at λmax and concentration of STV. The graphs showed
negligible intercept and are described by the equation:
Y = a + bX
(where Y = absorbance of 1-cm layer of solution; a =
intercept; b = slope and X = concentration in µg/mL).
Regression analysis of the Beer’s law data using the method
of least squares was made to evaluate the slope (b),
intercept (a) and correlation coefficient(r) for each system
and the values are presented in Table II. The optical
characteristics such as Beer’s law limits, molar absorptivity
and Sandell sensitivity values of both methods are also
given in Table II. The limits of detection (LOD) and
quantitation(LOQ) calculated according to ICH guidelines(
ICH guidelines, 1996) are also presented in Table II and
reveal the very high sensitivity of the spectrophotometric
methods.
TABLE II - Analytical and regression parameters of spectrophotometric methods
Parameter Method A Method B
λmax, nm 520 610
Beer’s law limits, µg/mL 0.2 – 2.0 1.0 – 10.0
Molar absorptivity, L/mol/cm 5.7×104 1.5×104
Sandell sensitivity, µg/cm2 0.004 0.015
Limit of detection, µg/mL 0.03 0.12
Limit of quantification, µg/mL 0.10 0.35
Regression equation, Y*
Intercept (a) -0.0028 -0.002
Slope (b) 0.2595 0.0651
Correlation coefficient, (r) 0.9995 0.9984
Sa 0.006 0.012
Sb 0.003 0.001
*Y = a+bX, where Y is the absorbance and X concentration in µg/mL; Sa= Standard deviation of intercept; Sb= Standard
deviation of slope.
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Method Validation
Intra-day and inter-day precision
To evaluate the precision of the methods, pure drug
solution at three different levels (within the working limits)
was analysed, each determination being repeated seven ti-
mes. The relative standard deviation (%) values were ≤ 2.0
and indicate the high precision for the methods. For a better
picture of reproducibility on a day-to-day basis, a series of
experiments were performed in which standard drug
solution at three different levels was determined each day
for five days with all solutions being prepared afresh each
day. The day-to-day relative standard deviation values were
in the range of 3.2-3.7% and represent the best appraisal of
the methods in routine use.
Application to analysis of commercial samples
In order to check the validity of the proposed
methods, STV was determined in some commercial
formulations. Table III gives the results of the
determination from which it is clear that there is close
agreement between the results obtained by the proposed
methods and the label claim. The results were also
compared statistically by a Student’s t- test for accuracy
and variance ratio F- test for precision with those of the
literature method (Sankar et al., 2002) at 95% confidence
level. The calculated t- and F-values (Table III) did not
exceed the tabulated values (t=2.77, F=6.39), indicating
that there was no significant difference between the
proposed methods and the reference method in respect to
accuracy and precision.
The accuracy and validity of the proposed methods
were further ascertained by performing recovery studies.
Pre-analysed tablet or capsule powder was spiked with
pure STV at three different levels and the total was found
by the proposed methods. Each determination was repeated
three times. The recovery of the pure drug added was
quantitative and revealed that co-formulated substances
such as talc, starch, gum acacia, lactose, sodium alginate,
magnesium stearate, calcium carbonate, calcium gluconate
and calcium dihydrogenorthophosphate did not interfere in
the determination. The results of recovery study are
compiled in Table IV.
CONCLUSIONS
Three useful micro methods for the determination of
STV have been developed and validated. The methods are
simple and rapid taking not more than 10-15 min for the
assay. The titrimetric method is the first ever proposed for
stavudine and is applicable over range 1.5 to 10.0 mg. Both
the spectrophotometric methods are more sensitive than the
existing UV and HPLC methods and are free from such
experimental variables as heating or extraction step. The
methods rely on the use of simple and cheap chemicals and
techniques but provide a sensitivity comparable to that
TABLE III - Results of determination of stavudine in formulations and statistical comparison with the literature method
% Found* ± SD
Brand name# Nominal Literature Titrimetry Method A Method B
amount (mg) method
VIROSTAVa 30.0 99.66±0.82 100.30±1.16 100.20±1.46 99.95±0.66
(Tablets) t=1.02 t=0.75 t=0.62
F=2.00 F=3.17 F=1.54
40.0 99.91±0.56 100.30±0.45 98.62±1.01 100.10±1.02
t=1.21 t=2.60 t=0.38
F=1.55 F=3.25 F=3.32
STAGb 30.0 102.3±0.51 101.60±0.39 101.95±1.02 100.60±1.16
(Capsules) t=2.46 t=0.72 t=0.57
F=1.71 F=4.00 F=5.17
40.0 100.5±0.62 101.10±0.55 99.95±1.32 101.90±1.33
t=1.61 t=0.90 t=2.27
F=1.27 F=4.53 F=4.60
*Mean value of five determinations; #Marketed by: a. Cross Lands.; b. Genix Ltd.; Tabulated t-value at 95% confidence
level is 2.77; Tabulated F-value at 95% confidence level is 6.39.
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achieved by sophisticated and expensive technique like
HPLC. Thus, they can be used as alternatives for rapid and
routine determination of bulk sample and tablets.
RESUMO
Uso de cloramina-T e de dois corantes na determina-
ção sensível de estavudina em medicamentos
Descrevem-se três novos métodos para o ensaio de
estavudina (STV) na matéria-prima e nas formulações
utilizando-se clroamina-T (CAT) e dois corantes,
alaranjado de metila e índigo carmim como reagentes.  A
titulação envolve o tratamento de STV com excesso medi-
do de CAT em meio de ácido clorídrico, e, quando a oxi-
dação se completar, o oxidante que não reagiu é determi-
nado iodometricamente. Os métodos espectrofotométricos
compreendem a adição de excesso conhecido de CAT ao
STV em ácido clorídrico, seguida da determinação do
oxidante residual por meio da reação com quantidade fi-
xada de alaranjado de metila, medindo-se a absorvância
a 520 nm (Método A) ou índigo carmim, medindo-se a
absorvância a 610 nm (Método B). Em todos os métodos,
a quantidade de CAT que reagiu corresponde à quantida-
de de STV. No método titulométrico, a reação segue a
estequiometria 1:1 (STV:CAT) e é aplicável na faixa de
1,5 a 10 mg de STV. Nos métodos espectrofotométricos, a
absorvância aumenta linearmente com a concentração de
STV. Os sistemas obedecem a lei de Beer nos intervalos de
0,2 a 2,0 mg/mL e 1,0 a 10,00 mg/mL para os métodos A
e B, respectivamente, e os valores de sensibilidade de
Sandell correspondentes são 0,004 e 0,015 µg/cm2. Os li-
mites de detecção e de quantificação são apresentados
para ambos os métodos. A precisão e a exatidão intra-dia
e inter-dia dos métodos desenvolvidos são avaliadas de
acordo com as normas ICH. Os métodos foram aplicados
com êxito aos ensaios de STV em comprimidos e em cáp-
sulas e os resultados foram comparáveis com aqueles ob-
tidos com o método de referência, utilizando-se o teste t de
Student e o teste F. Não se observou interferência dos
adjuvantes comuns em comprimidos. A exatidão e a
confiabilidade dos métodos foram ajustadas por meio de
experimentos de recuperação via método de adição de
padrão.
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